BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.400
+0.060 (4.48%)
At close: Nov 20, 2024, 4:00 PM
1.420
+0.020 (1.43%)
After-hours: Nov 20, 2024, 5:18 PM EST
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2023. The number of employees increased by 1 or 10.00% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
10.00%
Revenue / Employee
$34,273
Profits / Employee
-$177,589
Market Cap
9.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Evogene | 142 |
Evaxion Biotech | 49 |
Jaguar Health | 49 |
Senti Biosciences | 48 |
Quantum BioPharma | 17 |
Kiora Pharmaceuticals | 12 |
Ensysce Biosciences | 7 |
BRTX News
- 7 days ago - BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - GlobeNewsWire
- 6 weeks ago - BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 2 months ago - BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem® Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs - GlobeNewsWire
- 3 months ago - BioRestorative Therapies, Inc. (BRTX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - BioRestorative Therapies' Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine - GlobeNewsWire
- 5 months ago - BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program - GlobeNewsWire
- 5 months ago - BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results - GlobeNewsWire